1. Home
  2. SNDX vs WOOF Comparison

SNDX vs WOOF Comparison

Compare SNDX & WOOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Syndax Pharmaceuticals Inc.

SNDX

Syndax Pharmaceuticals Inc.

HOLD

Current Price

$21.89

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Petco Health and Wellness Company Inc.

WOOF

Petco Health and Wellness Company Inc.

HOLD

Current Price

$2.90

Market Cap

871.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNDX
WOOF
Founded
2005
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
871.9M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
SNDX
WOOF
Price
$21.89
$2.90
Analyst Decision
Strong Buy
Hold
Analyst Count
12
12
Target Price
$36.92
$3.92
AVG Volume (30 Days)
1.9M
3.4M
Earning Date
11-03-2025
11-25-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$111,304,000.00
$5,998,469,000.00
Revenue This Year
$620.14
N/A
Revenue Next Year
$115.42
$0.76
P/E Ratio
N/A
N/A
Revenue Growth
595.65
N/A
52 Week Low
$8.58
$2.28
52 Week High
$21.50
$4.51

Technical Indicators

Market Signals
Indicator
SNDX
WOOF
Relative Strength Index (RSI) 69.41 40.00
Support Level $19.72 $3.01
Resistance Level $21.43 $3.16
Average True Range (ATR) 0.97 0.10
MACD -0.01 -0.01
Stochastic Oscillator 71.55 19.51

Price Performance

Historical Comparison
SNDX
WOOF

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

About WOOF Petco Health and Wellness Company Inc.

Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.

Share on Social Networks: